Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Nilutamide

Related Products

Hot Products

Name

Nilutamide

EINECS N/A
CAS No. 63612-50-0 Density 1.463 g/cm3
PSA 95.23000 LogP 3.36540
Solubility N/A Melting Point 149 °C
Formula C12H10F3N3O4 Boiling Point N/A
Molecular Weight 317.224 Flash Point N/A
Transport Information UN 2811 6.1/PG 3 Appearance Crystalline solid
Safety 53-36/37/39-45 Risk Codes 60-25
Molecular Structure Molecular Structure of 63612-50-0 (Nilutamide) Hazard Symbols ToxicT
Synonyms

2,4-Imidazolidinedione,5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-;1-(3-Trifluoromethyl-4-nitrophenyl)-4,4-dimethylimidazolidine-2,5-dione;1-(3-Trifluoromethyl-4-nitrophenyl)-4,4-dimethylimidazoline-2,5-dione;Anandron;Nilandron;Nilandrone;RU 23908;RU 23908-10;

Article Data 3

Nilutamide Synthetic route

400-74-8

2-Fluoro-5-nitrobenzotrifluoride

1245322-30-8

5,5-dimethyl(trimethylsilyl)hydantoin

63612-50-0

nilutamide

Conditions
ConditionsYield
Stage #1: 2-Fluoro-5-nitrobenzotrifluoride With cesium fluoride In N,N-dimethyl-formamide for 0.166667h; Inert atmosphere;
Stage #2: 5,5-dimethyl(trimethylsilyl)hydantoin In N,N-dimethyl-formamide at 60℃; for 16h;
63612-50-0

nilutamide

3-(4-amino-3-(trifluoromethyl)phenyl)-5,5-dimethylimidazolidine-2,4-dione

Conditions
ConditionsYield
With hydrogen In tetrahydrofuran; water at 120℃; under 37503.8 Torr; for 15h; chemoselective reaction;96%
With formic acid; triethylamine In tetrahydrofuran at 100℃; for 15h; Inert atmosphere; Sealed tube; chemoselective reaction;96%
With formic acid; triethylamine for 24h; chemoselective reaction;94%
With tin(ll) chloride In ethanol
862700-62-7

methanesulfonic acid 9-(4,4,5,5,5-pentafluoro-pentyl-sulfanyl)-nonyl ester

63612-50-0

nilutamide

1252642-89-9

5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-1-{9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl}imidazolidine-2,4-dione

Conditions
ConditionsYield
Stage #1: nilutamide With sodium hydride In N,N-dimethyl-formamide at 23℃; for 1h; Inert atmosphere;
Stage #2: methanesulfonic acid 9-(4,4,5,5,5-pentafluoro-pentyl-sulfanyl)-nonyl ester In N,N-dimethyl-formamide for 15h; Inert atmosphere;
72%
628-77-3

1,5-diiodopentane

63612-50-0

nilutamide

1252642-93-5

1-(5-iodopentyl)-5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione

Conditions
ConditionsYield
Stage #1: nilutamide With sodium hydride In N,N-dimethyl-formamide at 23℃; for 1h; Inert atmosphere;
Stage #2: 1,5-diiodopentane In N,N-dimethyl-formamide for 15h; Inert atmosphere;
47%
110-52-1

1,4-dibromo-butane

63612-50-0

nilutamide

1252687-62-9

1,1'-butane-1,4-diylbis{5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)-phenyl]imidazolidine-2,4-dione}

Conditions
ConditionsYield
Stage #1: nilutamide With sodium hydride In N,N-dimethyl-formamide at 23℃; for 0.5h; Inert atmosphere;
Stage #2: 1,4-dibromo-butane In N,N-dimethyl-formamide at 55℃; for 1h; Inert atmosphere;
45%
141-32-2

acrylic acid n-butyl ester

63612-50-0

nilutamide

butyl (E)-3-(2-(4,4-dimethyl-2,5-dioxoimidazolidin-1-yl)-5-nitro-4-(trifluoromethyl)phenyl)acrylate

Conditions
ConditionsYield
With silver hexafluoroantimonate; [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2; copper(II) acetate monohydrate In 2-methyltetrahydrofuran at 100℃; for 18h; Sealed tube;14%
63612-50-0

nilutamide

1252642-90-2

5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-1-{9-[(4,4,5,5,5-pentafluoropentyl)sulphinyl]nonyl}imidazolidine-2,4-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium hydride / N,N-dimethyl-formamide / 1 h / 23 °C / Inert atmosphere
1.2: 15 h / Inert atmosphere
2.1: Oxone / water; tetrahydrofuran / 0.33 h
View Scheme
63612-50-0

nilutamide

1252642-91-3

5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-1-{9-[(4,4,5,5,5-pentafluoropentyl)sulphonyl]nonyl}imidazolidine-2,4-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: sodium hydride / N,N-dimethyl-formamide / 1 h / 23 °C / Inert atmosphere
1.2: 15 h / Inert atmosphere
2.1: Oxone / water; tetrahydrofuran / 0.33 h
3.1: Oxone / water; tetrahydrofuran / 3.5 h / 23 °C
View Scheme
63612-50-0

nilutamide

1252643-10-9

3-[4-amino-3-(trifluoromethyl)phenyl]-5,5-dimethyl-1-{9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl}imidazolidine-2,4-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium hydride / N,N-dimethyl-formamide / 1 h / 23 °C / Inert atmosphere
1.2: 15 h / Inert atmosphere
2.1: tin(II) chloride dihdyrate / ethyl acetate / 5.5 h / Reflux
View Scheme
63612-50-0

nilutamide

1252643-49-4

N-[(1Z)-(9-{5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-dioxoimidazolidin-1-yl}nonyl)(4,4,5,5,5-pentafluoropentyl)-λ4-sulphanylidene]-2,2,2-trifluoroacetamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium hydride / N,N-dimethyl-formamide / 1 h / 23 °C / Inert atmosphere
1.2: 15 h / Inert atmosphere
2.1: magnesium oxide; [bis(acetoxy)iodo]benzene / dirhodium tetraacetate / dichloromethane / 6 h / 23 °C
View Scheme

Nilutamide Chemical Properties

Molecular Formula: C12H10F3N3O4
Molecular Weight:: 317.22
Melting point:  149 °C 
RTECS: NI9453300
Merck: 12,6636
Form: Solid
Density: 1.463 g/cm3
Index of Refraction: 1.523
Appearance: Crystalline Solid
Surface Tension: 42.8 dyne/cm 
Solubility in water: Insoluble
Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals;Active Pharmaceutical Ingredients;Molecular Targeted Antineoplastic;Aromatics Compounds;Aromatics;Heterocycles
The molecular structure of Nilutamide (63612-50-0):
        

Nilutamide Uses

 Nilutamide (63612-50-0) is an antiandrogen medication used in the treatment of advanced stage prostate cancer. Nilutamide blocks the androgen receptor, preventing its interaction with testosterone. Because most prostate cancer cells rely on the stimulation of the androgen receptor for growth and survival, nilutamide can prolong life in men with prostate cancer.

Nilutamide Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 150mg/kg (150mg/kg)   Drugs of the Future. Vol. 12, Pg. 763, 1987.
mouse LD50 oral 200mg/kg (200mg/kg)   Drugs of the Future. Vol. 12, Pg. 763, 1987.
rat LD50 intraperitoneal 125mg/kg (125mg/kg)   Drugs of the Future. Vol. 12, Pg. 763, 1987.
rat LD50 oral 195mg/kg (195mg/kg)   Drugs of the Future. Vol. 12, Pg. 763, 1987.

Nilutamide Safety Profile

Hazard Codes: ToxicT
Risk Statements: 60-25
 R60:May impair fertility. 
 R25 :Toxic if swallowed.
Safety Statements: 53-36/37/39-45 
 S53:Avoid exposure - obtain special instructions before use. 
 S36/37/39:Wear suitable protective clothing, gloves and eye/face protection. 
 S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
RIDADR: UN 2811 6.1/PG 3
WGK Germany: 3
RTECS: NI9453300

Nilutamide Specification

 Nilutamide , its CAS number is 63612-50-0. The chemical synonyms of Nilutamide (63612-50-0) are Anandron ; 5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedione ; Nilandrone ; Nilutamida ; 1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazolidine-2,5-dione ; 5,5-Dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)-4-imidazolidinedione ; and 5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin 1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazolidine-2,5-dione .
 Nilutamide is marketed under the name Nilandron in the United States and under the name Anandron in Canada.
 Nilutamide should be stored in original container in a cool dark place. It will emits toxic fumes under fire conditions. If inhalate the product, first, remove to fresh air. If not breathing give artificial respiration. If breathing is difficult, give oxygen. Then seek medical attention at the same time. While on skin, immediately wash skin with soap and copious amounts of water for at least 15 minutes. If irritation persists, seek medical attention. When in eyes, immediately flush eyes with copious amounts of water for at least 15 minutes. Then seek medical advice. If swallowed the product, wash out mouth with water, provided person is conscious. Seek medical advice.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 63612-50-0